We are live on ! Find out more
AIC

Argus Investors Counsel Portfolio holdings

AUM $130M
1-Year Est. Return 37.06%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$156M
AUM Growth
+$17M
Cap. Flow
+$1.18M
Cap. Flow %
0.76%
Top 10 Hldgs %
27.12%
Holding
104
New
9
Increased
44
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$875K
2
CRM icon
Salesforce
CRM
+$844K
3
AMZN icon
Amazon
AMZN
+$826K
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$707K
5
ADI icon
Analog Devices
ADI
+$492K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$991K
2
APD icon
Air Products & Chemicals
APD
+$988K
3
AMT icon
American Tower
AMT
+$619K
4
LLY icon
Eli Lilly
LLY
+$541K
5
MRNA icon
Moderna
MRNA
+$527K

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Financials 16.39%
3 Healthcare 13.44%
4 Industrials 12.8%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBB icon
101
iShares MBS ETF
MBB
$39B
-5,147
Closed -$457K
MRK icon
102
Merck
MRK
$322B
-9,629
Closed -$991K
MRNA icon
103
Moderna
MRNA
$24.2B
-5,103
Closed -$527K
YUM icon
104
Yum! Brands
YUM
$39.5B
-2,516
Closed -$314K

Similar funds

Argus Investors Counsel's Q4 2023 Portfolio in Review

As of Q4 2023, Argus Investors Counsel held 104 positions worth $156M, up 12% from $139M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Argus Investors Counsel's Q4 2023 filing shows 9 new, 44 increased, 36 reduced and 6 closed positions. Its largest new stake was McKesson: 1,925 shares worth $891K. The largest sale was Merck, an estimated $991K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Argus Investors Counsel's largest Q4 2023 buy was McKesson: 1,925 shares worth $891K.
  • Argus Investors Counsel added most to Amazon in Q4 2023, an estimated $826K increase.
  • Argus Investors Counsel's biggest Q4 2023 reduction was Air Products & Chemicals, cutting an estimated $988K.
  • Argus Investors Counsel fully exited Merck in Q4 2023, selling an estimated $991K.
  • Argus Investors Counsel's ten largest holdings make up 27% of its $156M portfolio in Q4 2023.
  • Argus Investors Counsel opened 9 new positions and closed 6 in Q4 2023.
  • Argus Investors Counsel's portfolio value rose 12% quarter-over-quarter to $156M.

Based on Argus Investors Counsel's 13F filing for Q4 2023, filed 22 Jan 2024.